HIGHLIGHTS
- who: OPINION et al. from the State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, China have published the research: A Superstable Homogeneous Lipiodol-Nanoformulation to Overcome the Dilemma of Interventional Embolization Chemotherapy, in the Journal: (JOURNAL)
SUMMARY
Hepatocellular carcinoma (HCC) is one of the leading cancer-related death, with morbidity and mortality rates increasing annually. Clinical practice has shown that the choice of embolic agents is limited by postoperative recanalization, nontargeted embolization, etc (Chen et_al, 2020b; Jiang et_al . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.